Markets Gone Wild

Monthly Maintenance Dosing Approved for Alzheimer’s Drug Leqembi The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan’s Eisai and partner Biogen’s Alzheimer’s drug Leqembi, the companies said on Monday. Alzheimer’s disease is a devastating condition that affects millions of people worldwide. It slowly robs individuals of their memories and cognitive abilities,…

Investigation Initiated for Inari Medical, Inc. Investors by Bronstein, Gewirtz & Grossman, LLC New York City, NY / ACCESS Newswire / February 6, 2025 Bronstein, Gewirtz & Grossman, LLC is currently conducting an investigation into potential claims for purchasers of Inari Medical, Inc. (“Inari” or “the Company”) (NASDAQ:NARI). Investors who bought Inari securities prior to…

Altigen Communications, Inc. (ATGN) Q1 2025 Results Conference Call: Key Insights On February 27, 2025, Altigen Communications, Inc. (ATGN) held its Q1 2025 Results Conference Call. The call was led by Jerry Fleming, President and CEO, Gary Stone, Chief Financial Officer, and Joe Hamblin, Chief Digital & Transformation Officer. In this article, we’ll provide a…

Get Ready for a Pipe Dream Come True: The Surprising Impact of the Expanding PVC Pipes Market You might be wondering, “What on earth is the PVC Pipes Market and why should I care?” Well, dear reader, strap in and let me take you on a whimsical journey through the world of plastic pipes! The…

Welcome to the Exciting World of ASML Have you ever heard of ASML? No, it’s not some new texting abbreviation or slang term that the cool kids are using these days. It stands for Advanced Semiconductor Materials Lithography, and let me tell you, it’s a big deal in the tech world. The Power of Monopoly…

Qualcomm’s Diversification Strategy: Beyond Handsets Rapid Expansion into AI, Automotive, and IoT Qualcomm Incorporated, a leading semiconductor company, is making bold moves to diversify its revenue streams beyond traditional handsets. With a target of $22 billion in non-handset revenue by 2029, Qualcomm is focusing on key growth areas such as artificial intelligence (AI), automotive technology,…

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Regeneron Pharmaceuticals, Inc. Overview LOS ANGELES, CA / ACCESS Newswire / February 15, 2025 The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors about a class action lawsuit against Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ:REGN). The lawsuit is…